VerifiedBiotechnology Research· Founded 2018

Imbria Pharmaceuticals

Imbria is a privately held, clinical stage company developing novel therapies for patients with life-altering cardiometabolic disorders. Our clinical stage pipeline is focused on restoring or improving the cell’s ability to produce energy in cardiovascular disorders where energetic impairment is a fundamental contributor to symptoms and functional deficits. The lead product candidate, ninerafaxstat, is currently in Phase 2 clinical development in three indications: nHCM, stable angina, and HFpEF. For additional information, please visit

7-day free trial · no credit card

Boston, United States15(1 to 10)$1M to <$10M2018imbria.com LinkedIn

Verified contacts

11

available on Kipplo

LinkedIn employees

15

1 to 10 range

Open roles

—

no listings

Distinct roles

8

indexed titles

Tech stack

3

tools in use

Monthly traffic

63

organic / mo

Sign up free to see all 11 verified contacts at Imbria Pharmaceuticals

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

11 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 5 of 11 verified contacts

Top roles at Imbria Pharmaceuticals

8 distinct titles indexed · top 8 shown.

2executive assistant & operations lead
1()
1chief scientific officer
1clinical trial manager
1director, clinical operations
1president and ceo
1senior director, cmc
1senior vice president, regulatory affairs, quality, and cmc

Sign up to unlock all 11 contacts at Imbria Pharmaceuticals

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 11 verified contacts at Imbria Pharmaceuticals

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Imbria Pharmaceuticals | Kipplo Discover